Compound ID | 1130
Synonym(s): GV118819
Class: Beta-lactam
Spectrum of activity: | Gram-positive |
Details of activity: | Orally available prodrug ester of GV104326, improved activity against gram positive pathogens. |
Description: | Hammond.S,M., et al. "GV118819 an orally absorbed prodrug ester of the tribactam GV104326"" Program and Abstracts of the 32st Intersci. Conf. on Antimicrob. Agents Chemother. No. 130. |
Institute where first reported: | GlaxoSmithKline |
Year first mentioned: | 1992 |
Highest developmental phase: | Phase 2 |
Development status: | Inactive |
Reason Dropped: | Discontinued in 1999 |
Chemical structure(s): | |
Canonical SMILES: | C[C@H]([C@@H]1[C@H]2[C@H]3CCC[C@@H](C3=C(C(=O)OC(C)OC(=O)OC4CCCCC4)N2C1=O)OC)O |
Isomeric SMILES: | C[C@H]([C@@H]1[C@H]2[C@H]3CCC[C@@H](C3=C(N2C1=O)C(=O)OC(C)OC(=O)OC4CCCCC4)OC)O |
InChI: | InChI=1S/C23H33NO8/c1-12(25)17-19-15-10-7-11-16(29-3)18(15)20(24(19)21(17)26)22(27)30-13(2)31-23(28)32-14-8-5-4-6-9-14/h12-17,19,25H,4-11H2,1-3H3/t12-,13?,15+,16+,17-,19-/m1/s1 |
InChI Key: | QFEICXCLIGZEJB-IRVPUMQPSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/6918217 |
External links: | |
Guide to Pharmacology: | sanfetrinem |